Dura Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-06-2024
- Paid Up Capital ₹ 0.50 M
as on 24-06-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Profit 3.64%
(FY 2019)
- Ebitda 42.52%
(FY 2019)
- Net Worth -44.59%
(FY 2019)
- Total Assets -37.86%
(FY 2019)
About Dura Lifesciences
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Srilakshmi Kudaravalli, Kudaravalli Durgarani, and Kudaravalli Rao serve as directors at the Company.
- CIN/LLPIN
U73100TG2008PLC057638
- Company No.
057638
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dura Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srilakshmi Kudaravalli  | Director | 16-Aug-2023 | Current |
| Kudaravalli Durgarani | Director | 18-Feb-2008 | Current |
| Kudaravalli Rao | Director | 18-Feb-2008 | Current |
Financial Performance and Corporate Structure Insights of Dura Lifesciences.
Dura Lifesciences Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dura Lifesciences?
In 2018, Dura Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kekule Pharma LimitedActive 40 years 20 daysSrilakshmi Kudaravalli, Kudaravalli Durgarani and 1 more are mutual person
- Kekule Pharmaceuticals (A.P) LimitedActive 9 years 8 months
Srilakshmi Kudaravalli, Kudaravalli Durgarani and 1 more are mutual person
Kekule Life Sciences LimitedActive 11 years 4 monthsSrilakshmi Kudaravalli and Kudaravalli Rao are mutual person
Premier Klenz Private LimitedActive 43 years 11 monthsKudaravalli Durgarani and Kudaravalli Rao are mutual person
- Dura Estates Private LimitedActive 18 years 1 month
Kudaravalli Durgarani and Kudaravalli Rao are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dura Lifesciences?
Unlock and access historical data on people associated with Dura Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dura Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dura Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
